Potency Meets Precision in Nano-optimized Chemotherapeutics

Artavazd Arumov, Asaad Trabolsi, Jonathan H. Schatz

Research output: Contribution to journalShort surveypeer-review

6 Scopus citations


Chemotherapy remains the most widely used cancer treatment modality. Nanotechnology provides exciting opportunities to improve these drugs, transforming decades-old generic treatments into precise new medicines. We illustrate the potential of recent advances in nanotechnology-enhanced therapy focusing on diffuse large B-cell lymphoma (DLBCL); the most common hematologic malignancy.

Original languageEnglish (US)
Pages (from-to)974-977
Number of pages4
JournalTrends in Biotechnology
Issue number10
StatePublished - Oct 2021


  • cancer
  • drug delivery
  • lymphoma
  • nanotechnology
  • precision medicine
  • therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering


Dive into the research topics of 'Potency Meets Precision in Nano-optimized Chemotherapeutics'. Together they form a unique fingerprint.

Cite this